Our first experience of gemcitabine and nab-paclitaxel combination therapy for borderline resectable pancreatic cancer

Our first experience of gemcitabine and nab-paclitaxel combination therapy for borderline resectable pancreatic cancer

According to NCCN 2013 criteria, 24 patients were diagnosed as BRPC.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016-08, Vol.16 (4), p.S167-S167
Hauptverfasser: Matsumoto, Takatsugu, Aoki, Taku, Iso, Yukihiro, Tanaka, Genki, Tago, Kazuma, Sakuraoka, Yuhki, Shiraki, Takayuki, Kosuge, Takayuki, Kato, Masato, Ishizuka, Mitsuru, Kubota, Keiichi
Format: Artikel
Sprache:eng
Schlagworte:
Endocrinology & Metabolism
Gastroenterology and Hepatology
Pancreatic cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:According to NCCN 2013 criteria, 24 patients were diagnosed as BRPC.
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2016.06.600